Glycan Therapeutics
Pioneer in development of carbohydrate based drug. Our platform technology delivers structurally defined synthetic heparin scalable to replace the multibillion dollar animal based anticoagulant heparin. Our services include heparan sulfate microarray and a novel highly sensitive LC-MS based detection of heparan sulfate from body fluids and tissues.
7-day free trial · no credit card
Verified contacts
8
available on Kipplo
LinkedIn employees
11
11 to 50 range
Open roles
—
no listings
Distinct roles
7
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 8 verified contacts at Glycan Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
8 contacts with verified email or phone · masked until revealed.
- VP
Vijayakanth Pagadala
Chief Operating Officer · Other
EmailPhone - ES
Eduardo Stancanelli
Principal Scientist · Science
EmailPhone - TK
Tomasz Kozlowski
Medical Consultant · Healthcare & Human Services
EmailPhone - ZW
Zhangjie Wang
Principal Scientist · Science
EmailPhone
Showing 4 of 8 verified contacts
Top roles at Glycan Therapeutics
7 distinct titles indexed · top 7 shown.
- 2principal scientist
- 1associate scientist
- 1chief operating officer
- 1client care specialist
- 1intern
- 1medical consultant
- 1web development programmer
Sign up to unlock all 8 contacts at Glycan Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 8 verified contacts at Glycan Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.